Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 23, 2022 09:15 ET | Source: Nutra Pharma Corp.

Nutra Pharma Announces First Manufacturing Agreement

Plantation, Florida, March 23, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in...
March 17, 2022 09:15 ET | Source: Nutra Pharma Corp.

Nutra Pharma Expands Manufacturing Capabilities

Plantation, Florida, March 17, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in...
December 20, 2012 14:27 ET | Source: Nutra Pharma Corporation

Nutra Pharma Provides Sales and Marketing Update

Nutra Pharma is providing an update on the sales and marketing efforts of TCN as they begin their global marketing campaign for Nutra Pharma's over-the-counter (OTC) pain reliever,...
December 19, 2012 09:15 ET | Source: Nutra Pharma Corporation

Nutra Pharma Introduces Nyloxin(TM) Military Strength

CORAL SPRINGS, Fla., Dec. 19, 2012 (GLOBE NEWSWIRE) -- Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple...
December 18, 2012 09:43 ET | Source: Nutra Pharma Corporation

Nutra Pharma Letter to Shareholders

CORAL SPRINGS, Fla., Dec. 18, 2012 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTCQB:NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency...
May 02, 2012 09:18 ET | Source: Nutra Pharma Corporation

Nutra Pharma Begins Affiliate Sales & Marketing Program for the Distribution of Nyloxin(TM)

CORAL SPRINGS, Fla., May 2, 2012 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTCBB:NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency...